hypertension

hypertension
Name	Hypertension
Synonyms	High blood pressure, arterial hypertension
Field	Cardiology, Internal medicine
Symptoms	Headache, dizziness, asymptomatic
Complications	Stroke, Myocardial infarction, chronic kidney disease, heart failure
Onset	Variable
Causes	Multifactorial
Risks	Age, family history, obesity, smoking, excessive alcohol, diet high in sodium
Diagnosis	Blood pressure measurement, ambulatory monitoring
Treatment	Lifestyle modification, antihypertensive medication

hypertension

Hypertension is a common chronic medical condition characterized by persistently elevated arterial pressure that increases risk for vascular events and target-organ damage. It is a major contributor to global morbidity and mortality and is managed across specialties including Cardiology, Nephrology, and Endocrinology. Guidelines for diagnosis and treatment have been produced by organizations such as the World Health Organization, the American Heart Association, and the European Society of Cardiology.

Definition and Classification

Blood pressure thresholds and categories are defined by guideline bodies like the American College of Cardiology, the American Heart Association, the European Society of Hypertension, and the National Institute for Health and Care Excellence. Classification schemes use systolic and diastolic values measured by sphygmomanometer and ambulatory monitors following protocols endorsed by the World Health Organization and national agencies. Subtypes include primary (essential) forms, secondary causes linked to conditions such as Primary aldosteronism, Pheochromocytoma, renovascular disease from Atherosclerosis, and pregnancy-associated variants including Preeclampsia. Special classifications exist for isolated systolic elevation, masked forms identified in workplace or community screening initiatives like those promoted by the Centers for Disease Control and Prevention, and resistant patterns discussed in literature from institutions such as the Mayo Clinic.

Epidemiology and Risk Factors

Prevalence estimates derive from population studies like the Framingham Heart Study, the Global Burden of Disease Study, and national surveys by the National Health and Nutrition Examination Survey. Risk increases with age cohorts examined in longitudinal cohorts at institutions including Johns Hopkins University and Harvard Medical School. Major risk determinants include family history observed in pedigree analyses at centers such as the Broad Institute, behavioral exposures documented in reports by the World Health Organization and Centers for Disease Control and Prevention (tobacco, alcohol), dietary patterns analyzed in studies by the Oxford-based EPIC study, and comorbid states such as Type 2 diabetes mellitus cohorts reported by the Diabetes Control and Complications Trial and chronic kidney disease populations tracked by the National Kidney Foundation.

Pathophysiology

Mechanisms integrate hemodynamic, renal, neurohormonal, and vascular components described in textbooks from publishers like Oxford University Press and research from laboratories at institutions including Massachusetts General Hospital and the Salk Institute. Pathways involve dysregulation of the renin–angiotensin–aldosterone system detailed in classical experiments at the National Institutes of Health, sympathetic nervous system hyperactivity studied in trials at the Cleveland Clinic, endothelial dysfunction characterized in work from Imperial College London, and structural remodeling of arteries reported by groups at Karolinska Institutet. Genetic contributors have been mapped through consortia including the International Consortium for Blood Pressure (ICBP) and genomic initiatives at the Wellcome Trust Sanger Institute.

Clinical Presentation and Diagnosis

Many individuals are asymptomatic and are identified by screening programs run by agencies like the American Heart Association or during primary care visits in systems such as the National Health Service. Symptomatic presentations that prompt evaluation include headache, visual changes, chest pain linked to events evaluated by Emergency Medical Services teams, and neurological deficits consistent with Stroke pathways coordinated through comprehensive stroke centers like those at Mount Sinai Health System. Diagnostic workup employs standardized office measurements, validated ambulatory blood pressure monitoring devices approved by regulatory bodies like the Food and Drug Administration, and assessment for secondary causes using imaging at radiology centers affiliated with institutions such as Stanford Health Care. Risk stratification often incorporates calculators developed by consortia including the Framingham Heart Study group and guideline committees at the European Society of Cardiology.

Management and Treatment

Therapeutic strategies combine lifestyle interventions advocated by the World Health Organization and pharmacotherapy detailed in guidelines from the American College of Cardiology and the European Society of Hypertension. First-line drug classes include thiazide diuretics referenced in trials like ALLHAT conducted by the National Heart, Lung, and Blood Institute, angiotensin-converting enzyme inhibitors whose evidence base includes studies from the Anglo-Scandinavian Cardiac Outcomes Trial investigators, angiotensin receptor blockers evaluated in multicenter trials coordinated by entities such as the British Heart Foundation, calcium channel blockers studied in randomized trials at centers including Vanderbilt University Medical Center, and beta-blockers reviewed in meta-analyses by the Cochrane Collaboration. Resistant cases may be considered for interventions investigated by teams at the Baylor College of Medicine and device trials sponsored by consortia including industry partners and academic centers.

Complications and Prognosis

Untreated or poorly controlled disease increases risk for cardiovascular events such as Myocardial infarction, heart failure documented in registries like those maintained by the American College of Cardiology, stroke tracked by the Global Burden of Disease Study, chronic kidney disease monitored by the National Kidney Foundation, and retinopathy assessed in ophthalmology units at institutions like Bascom Palmer Eye Institute. Prognosis improves with risk-factor modification and therapeutic adherence supported by programs from the World Health Organization, the American Heart Association, and integrated care models developed at centers such as Geisinger Health System.

Prevention and Public Health Measures

Population strategies include salt-reduction campaigns led by the World Health Organization and national policy initiatives enacted by ministries of health in countries such as United Kingdom and United States. Screening programs have been implemented in community settings through collaborations with organizations like the Red Cross and workplace health schemes studied by groups at Harvard T.H. Chan School of Public Health. Prevention efforts prioritize healthy diets promoted in dietary guidelines from the United States Department of Agriculture, physical activity recommendations from the World Health Organization, tobacco control measures advanced by the World Health Organization Framework Convention on Tobacco Control, and alcohol policy approaches informed by research at the Institute of Alcohol Studies.

Category:Cardiovascular diseases